We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.97%
AUM
$48.5B
AUM Growth
+$1.47B
Cap. Flow
-$1.53B
Cap. Flow %
-3.15%
Top 10 Hldgs %
6.63%
Holding
1,973
New
160
Increased
850
Reduced
654
Closed
189

Sector Composition

Rank Sector Weight
1 Financials 17.89%
2 Industrials 14.53%
3 Technology 14.21%
4 Consumer Discretionary 11.69%
5 Healthcare 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUOT
1726
DELISTED
Quotient Technology Inc
QUOT
$19K ﹤0.01%
+1,221
New +$17.8K
ADMS
1727
DELISTED
Adamas Pharmaceuticals
ADMS
$19K ﹤0.01%
973
+128
+15% +$3.01K
OLBK
1728
DELISTED
Old Line Bancshares, Inc.
OLBK
$18K ﹤0.01%
561
FLO icon
1729
Flowers Foods
FLO
$1.54B
$17K ﹤0.01%
914
+306
+50% +$6.18K
SKT icon
1730
Tanger
SKT
$4.49B
$17K ﹤0.01%
765
CBAY
1731
DELISTED
Cymabay Therapeutics
CBAY
$17K ﹤0.01%
1,522
+200
+15% +$2.48K
BVH
1732
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$17K ﹤0.01%
454
-6,757
-94% -$270K
BNGOW
1733
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
$17K ﹤0.01%
+8,136
New +$16.2K
IWM icon
1734
iShares Russell 2000 ETF
IWM
$82.6B
$16K ﹤0.01%
95
+92
+3,067% +$15.5K
KFY icon
1735
Korn Ferry
KFY
$4.23B
$16K ﹤0.01%
323
-8,930
-97% -$550K
LCNB icon
1736
LCNB Corp
LCNB
$285M
$16K ﹤0.01%
833
NEWR
1737
DELISTED
New Relic, Inc.
NEWR
$16K ﹤0.01%
165
+39
+31% +$4.04K
MNTV
1738
DELISTED
Momentive Global Inc. Common Stock
MNTV
$16K ﹤0.01%
+1,000
New +$16.5K
CASH icon
1739
Pathward Financial
CASH
$1.85B
$15K ﹤0.01%
546
-5,364
-91% -$161K
IWR icon
1740
iShares Russell Mid-Cap ETF
IWR
$57.1B
$15K ﹤0.01%
276
+268
+3,350% +$14.7K
ABEO icon
1741
Abeona Therapeutics
ABEO
$396M
$14K ﹤0.01%
43
+6
+16% +$2.13K
ESPR
1742
DELISTED
Esperion Therapeutics
ESPR
$14K ﹤0.01%
325
+43
+15% +$1.97K
EXP icon
1743
Eagle Materials
EXP
$6.48B
$13K ﹤0.01%
149
-417,916
-100% -$40.6M
TGTX icon
1744
TG Therapeutics
TGTX
$7.56B
$12K ﹤0.01%
2,119
+278
+15% +$3.18K
CDTX
1745
DELISTED
Cidara Therapeutics
CDTX
$11K ﹤0.01%
127
+17
+15% +$1.5K
KDNY
1746
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$9K ﹤0.01%
242
+32
+15% +$1.03K
WPG
1747
DELISTED
Washington Prime Group Inc.
WPG
$7K ﹤0.01%
114
SNX icon
1748
TD Synnex
SNX
$20.6B
$1K ﹤0.01%
18
-768,370
-100% -$37M
ACAD icon
1749
Acadia Pharmaceuticals
ACAD
$4.86B
-513
Closed -$8K
ACM icon
1750
Aecom
ACM
$9.71B
-84,706
Closed -$2.8M

Similar funds

Victory Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Victory Capital Management held 1,973 positions worth $48.5B, up 3.1% from $47B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Victory Capital Management withdrew a net $1.53B in Q3 2018, closing 189 positions and reducing 654 holdings. Its most notable exit was Validus Hold Ltd, an estimated $110M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Victory Capital Management opened a new position in Healthcare Realty worth $180M.

  • Victory Capital Management's largest Q3 2018 buy was Healthcare Realty: 6,766,300 shares worth $180M.
  • Victory Capital Management added most to Carter's in Q3 2018, an estimated $228M increase.
  • Victory Capital Management's biggest Q3 2018 reduction was Energen, cutting an estimated $193M.
  • Victory Capital Management fully exited Validus Hold Ltd in Q3 2018, selling an estimated $110M.
  • Victory Capital Management's ten largest holdings make up 6.6% of its $48.5B portfolio in Q3 2018.
  • Victory Capital Management opened 160 new positions and closed 189 in Q3 2018.
  • Victory Capital Management's portfolio value rose 3.1% quarter-over-quarter to $48.5B.

Based on Victory Capital Management's 13F filing for Q3 2018, filed 1 Nov 2018.